NCT03284879View on ClinicalTrials.gov

Post-Marketing Surveillance Study of OTEZLA

CompletedOBSERVATIONAL
Enrollment

1,086

Participants

Timeline

Start Date

September 5, 2017

Primary Completion Date

October 31, 2021

Study Completion Date

March 20, 2022

Conditions
Psoriasis
Trial Locations (1)

804-0081

Tugi dermatology clinic, Kitakyushu

Sponsors

Lead Sponsor

Amgen
All Listed Sponsors
lead

Amgen

INDUSTRY

NCT03284879 - Post-Marketing Surveillance Study of OTEZLA | Biotech Hunter | Biotech Hunter